Annual ROE
-193.23%
-82.27%-74.14%
December 31, 2023
Summary
- As of February 7, 2025, RARE annual return on equity is -193.23%, with the most recent change of -82.27% (-74.14%) on December 31, 2023.
- During the last 3 years, RARE annual ROE has fallen by -172.59% (-836.19%).
- RARE annual ROE is now -897.57% below its all-time high of -19.37%, reached on December 31, 2012.
Performance
RARE ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly ROE
-226.56%
+63.44%+21.88%
September 30, 2024
Summary
- As of February 7, 2025, RARE quarterly return on equity is -226.56%, with the most recent change of +63.44% (+21.88%) on September 30, 2024.
- Over the past year, RARE quarterly ROE has increased by +37.58% (+14.23%).
- RARE quarterly ROE is now -3772.82% below its all-time high of -5.85%, reached on December 31, 2012.
Performance
RARE Quarterly ROE Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
ROE Formula
ROE = Net Income
Shareholders Equity ✕ 100%
Shareholders Equity ✕ 100%
RARE ROE Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -74.1% | +14.2% |
| 3 y3 years | -836.2% | -509.2% |
| 5 y5 years | -385.1% | -323.2% |
RARE ROE Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -342.0% | at low | -402.7% | +41.1% |
| 5 y | 5-year | -836.2% | at low | -830.0% | +41.1% |
| alltime | all time | -897.6% | at low | -3772.8% | +41.1% |
Ultragenyx Pharmaceutical ROE History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -226.56%(-21.9%) |
| Jun 2024 | - | -290.00%(-24.6%) |
| Mar 2024 | - | -384.83%(+28.0%) |
| Dec 2023 | -193.23%(+74.1%) | -300.57%(+13.8%) |
| Sep 2023 | - | -264.14%(+35.5%) |
| Jun 2023 | - | -194.91%(+36.4%) |
| Mar 2023 | - | -142.88%(+30.0%) |
| Dec 2022 | -110.96%(+153.8%) | -109.90%(+23.2%) |
| Sep 2022 | - | -89.23%(+51.8%) |
| Jun 2022 | - | -58.79%(+17.0%) |
| Mar 2022 | - | -50.24%(+11.5%) |
| Dec 2021 | -43.72%(+111.8%) | -45.07%(+21.2%) |
| Sep 2021 | - | -37.19%(-3.9%) |
| Jun 2021 | - | -38.68%(+58.8%) |
| Mar 2021 | - | -24.36%(-1.3%) |
| Dec 2020 | -20.64%(-67.6%) | -24.68%(-35.5%) |
| Sep 2020 | - | -38.24%(-10.8%) |
| Jun 2020 | - | -42.86%(-25.4%) |
| Mar 2020 | - | -57.48%(+5.5%) |
| Dec 2019 | -63.79%(+60.2%) | -54.47%(+1.7%) |
| Sep 2019 | - | -53.54%(+6.3%) |
| Jun 2019 | - | -50.39%(+11.3%) |
| Mar 2019 | - | -45.26%(+41.2%) |
| Dec 2018 | -39.83% | -32.05%(-5.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2018 | - | -33.73%(-4.1%) |
| Jun 2018 | - | -35.19%(-17.4%) |
| Mar 2018 | - | -42.58%(-39.7%) |
| Dec 2017 | -70.48%(+44.0%) | -70.56%(+7.1%) |
| Sep 2017 | - | -65.89%(+8.9%) |
| Jun 2017 | - | -60.52%(+8.9%) |
| Mar 2017 | - | -55.57%(+5.3%) |
| Dec 2016 | -48.93%(+78.4%) | -52.77%(+10.3%) |
| Sep 2016 | - | -47.86%(+19.7%) |
| Jun 2016 | - | -40.00%(+8.3%) |
| Mar 2016 | - | -36.93%(+12.1%) |
| Dec 2015 | -27.42%(-15.2%) | -32.94%(+9.3%) |
| Sep 2015 | - | -30.13%(-6.0%) |
| Jun 2015 | - | -32.07%(+4.3%) |
| Mar 2015 | - | -30.76%(-9.6%) |
| Dec 2014 | -32.34%(-53.8%) | -34.02%(-11.1%) |
| Sep 2014 | - | -38.28%(-12.4%) |
| Jun 2014 | - | -43.68%(-3.9%) |
| Mar 2014 | - | -45.45%(-27.9%) |
| Dec 2013 | -69.99%(+261.3%) | -63.04%(+59.9%) |
| Sep 2013 | - | -39.43%(+64.2%) |
| Jun 2013 | - | -24.02%(+73.7%) |
| Mar 2013 | - | -13.83%(+136.4%) |
| Dec 2012 | -19.37%(-69.9%) | -5.85% |
| Dec 2011 | -64.35% | - |
FAQ
- What is Ultragenyx Pharmaceutical annual return on equity?
- What is the all time high annual ROE for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical annual ROE year-on-year change?
- What is Ultragenyx Pharmaceutical quarterly return on equity?
- What is the all time high quarterly ROE for Ultragenyx Pharmaceutical?
- What is Ultragenyx Pharmaceutical quarterly ROE year-on-year change?
What is Ultragenyx Pharmaceutical annual return on equity?
The current annual ROE of RARE is -193.23%
What is the all time high annual ROE for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high annual return on equity is -19.37%
What is Ultragenyx Pharmaceutical annual ROE year-on-year change?
Over the past year, RARE annual return on equity has changed by -82.27% (-74.14%)
What is Ultragenyx Pharmaceutical quarterly return on equity?
The current quarterly ROE of RARE is -226.56%
What is the all time high quarterly ROE for Ultragenyx Pharmaceutical?
Ultragenyx Pharmaceutical all-time high quarterly return on equity is -5.85%
What is Ultragenyx Pharmaceutical quarterly ROE year-on-year change?
Over the past year, RARE quarterly return on equity has changed by +37.58% (+14.23%)